A prospective study for nano carbon combined with fluorescence tracing in sentinel lymph node biopsy of thyroid papillary carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027016

Enrollment

Unknown

Registered

2019-10-28

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid carcinoma

Interventions

A:Nano carbon dyeing

B:Indocyanine green staining

C:Nano carbon combined with indocyanine green dyeing

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Thyroid cancer patients admitted from November 2019 to November 2020.

Exclusion criteria

Exclusion criteria: History of thyroid surgery and neck radiotherapy; exclusion of benign cases with rapid pathological changes during operation; central liquefying necrosis, peripheral enhancement and disappearance of fat space beside node, etc..

Design outcomes

Primary

Measure	Time frame
lymph node;Complication;	—

Countries

China

Contacts

Public ContactShao Jie

North Hospital of Huashan Hospital Affiliated to Fudan University

Drshaojie@163.com+86 13818718245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026